The mouse transcription factor PEBP2 is a heterodimer of two subunits: a DNA binding subunit α and its partner subunit β. The α subunit shares a region of high homology, termed the Runt domain, with the products of the Drosophila melanogaster segmentation gene runt and the human acute myeloid leukemia-related gene AML1. To study the molecular basis for the DNA binding and heterodimerization functions of this factor, we constructed series of deletions of the α and β subunits and examined their activities by electrophoretic mobility shift and affinity column assays. The minimal functional region of the α subunit for DNA binding and dimerization was shown to coincide with the Runt domain. On the other hand, the region of the β subunit required for heterodimerization was localized to the N-terminal 135 amino acids. Furthermore, it was found that the DNA binding activity of the Runt domain is regulated by a reduction/oxidization (redox) mechanism and that its reductively activated state, which is extremely labile, is stabilized by the β subunit. These findings add a new layer to the mechanism and significance of the regulatory interplay between the two subunits of PEBP2. The mouse transcription factor PEBP2 is a heterodimer of two subunits: a DNA binding subunit α and its partner subunit β. The α subunit shares a region of high homology, termed the Runt domain, with the products of the Drosophila melanogaster segmentation gene runt and the human acute myeloid leukemia-related gene AML1. To study the molecular basis for the DNA binding and heterodimerization functions of this factor, we constructed series of deletions of the α and β subunits and examined their activities by electrophoretic mobility shift and affinity column assays. The minimal functional region of the α subunit for DNA binding and dimerization was shown to coincide with the Runt domain. On the other hand, the region of the β subunit required for heterodimerization was localized to the N-terminal 135 amino acids. Furthermore, it was found that the DNA binding activity of the Runt domain is regulated by a reduction/oxidization (redox) mechanism and that its reductively activated state, which is extremely labile, is stabilized by the β subunit. These findings add a new layer to the mechanism and significance of the regulatory interplay between the two subunits of PEBP2.
No takes yet. Share an insight, caveat, or question.
Kagoshima et al. (1996) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: